Australia markets open in 6 hours 19 minutes

Biohaven Ltd. (BHVN)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
36.32-0.06 (-0.16%)
As of 01:41PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.44B
Enterprise value 3.03B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)8.96
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.19

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 389.38%
S&P500 52-week change 322.62%
52-week high 362.21
52-week low 316.45
50-day moving average 337.77
200-day moving average 341.66

Share statistics

Avg vol (3-month) 3929.66k
Avg vol (10-day) 3710.35k
Shares outstanding 594.54M
Implied shares outstanding 694.54M
Float 877.72M
% held by insiders 112.00%
% held by institutions 189.25%
Shares short (15 Aug 2024) 410.29M
Short ratio (15 Aug 2024) 412.14
Short % of float (15 Aug 2024) 412.33%
Short % of shares outstanding (15 Aug 2024) 410.88%
Shares short (prior month 15 July 2024) 49.81M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-89.65%
Return on equity (ttm)-193.67%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -774.44M
Net income avi to common (ttm)-746.6M
Diluted EPS (ttm)-9.30
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)436.95M
Total cash per share (mrq)4.62
Total debt (mrq)29.74M
Total debt/equity (mrq)7.75%
Current ratio (mrq)3.27
Book value per share (mrq)4.16

Cash flow statement

Operating cash flow (ttm)-480.13M
Levered free cash flow (ttm)-291.04M